Systemic administration of humanized anti-IgE antibodies causes a 95–99% decrease in serum IgE, along with anti-inflammatory feature of asthma [2], which supports the IgE-mediated mechanism of atopic asthma. The gene discussed is IGHE; the disease is asthma.